Table 7

Correlation between pre-test probabilities and mutation prevalence in breast/ovarian families

Pre-test probability quartiles
Model1st (n=10)2nd (n=9)3rd (n=9)4th (n=9)Correlation coeficient
HCSC
    Average pre-test probability0.160.280.440.770.85
    Prevalence of mutations (95% CI)0.20 (0.06 to 0.51)0.66 (0.35 to 0.88)0.55 (0.28 to 0.81)0.89 (0.57 to 0.98)p=NS
LUMC
    Average pre-test probability0.120.270.480.810.72
    Prevalence of mutations (95% CI)0.30 (0.11 to 0.60)0.55 (0.26 to 0.81)0.77 (0.45 to 0.93)0.66 (0.35 to 0.88)p=NS
U Penn
    Average pre-test probability0.140.260.400.690.88
    Prevalence of mutations (95% CI)40 (0.17 to 0.69)0.55 (0.26 to 0.81)0.44 (0.19 to 0.73)0.89 (0.57 to 0.98)p=NS
HUCH
    Average pre-test probability0.220.410.600.870.50
    Prevalence of mutations (95% CI)30 (0.11 to 0.60)0.55 (0.26 to 0.81)0.88 (0.57 to 0.98)0.55 (0.26 to 0.81)p=NS
Frank 2002
    Average pre-test probability0.210.410.510.720.933
    Prevalence of mutations (95% CI)0.10 (0.02 to 0.40)0.66 (0.35 to 0.98)0.66 (0.35 to 0.98)0.88 (0.57 to 0.98)p=NS
Risk counsellor
    Average pre-test probability0.390.590.690.760.847
    Prevalence of mutations (95% CI)0.50 (0.24 to 0.76)0.55 (0.26 to 0.81)0.55 (0.26 to 0.81)0.66 (0.35 to 0.88)p=NS